Year: 2019
Type: review
Abstract: Obesity is a chronic metabolic disease caused by multiple factors and is considered to be a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and various cancers. Hesperidin, a flavanone glycoside, is a natural phenolic compound with a wide range of biological effects. Mounting evidence has demonstrated that hesperidin possesses inhibitory effect against obesity diseases. Our review discusses mechanisms of hesperidin in the treatment of obesity. Hesperidin regulates lipid metabolism and glucose metabolism by mediating AMPK and PPAR signaling pathways, directly regulates antioxidant index and anti-apoptosis, and indirectly mediates NF-κB signaling pathway to regulate inflammation to play a role in the treatment of obesity. In addition, hesperidin-enriched dietary supplements can significantly improve symptoms such as postprandial hyperglycemia and hyperlipidemia. Further clinical trials are also required for confirming lipid-lowering efficacy of this natural flavonoid and evaluating its safety profile.
DOI: 10.2147/dddt.s227499
Authors: Haijun Xiong, Jin Wang, Qian Ran, Guanhua Lou, Chengyi Peng, Qingxia Gan, Ju Hu, Jilin Sun, Renchuan Yao, Qinwan Huang
Institution: Chengdu University of Traditional Chinese Medicine
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Keywords: hesperidin, obesity, flavanone glycosides, natural phenolic compounds, AMPK signaling, PPAR signaling, NF-κB signaling, lipid metabolism, glucose metabolism, antioxidant activity, apoptosis inhibition, inflammation, postprandial hyperglycemia, hyperlipidemia, dietary supplements, type 2 diabetes
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W2982788023
